Found: 604
Select item for more details and to access through your institution.
Injurious Fall Risk Differences Among Older Adults With First-Line Depression Treatments.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2435535, doi. 10.1001/jamanetworkopen.2024.35535
- By:
- Publication type:
- Article
Affective Disorders.
- Published in:
- Current Medical Literature: Psychiatry, 2010, v. 21, n. 3, p. 99
- Publication type:
- Article
Anxiety Disorders.
- Published in:
- Current Medical Literature: Psychiatry, 2009, v. 20, n. 4, p. 97
- Publication type:
- Article
Construction and Performance Characterization of Ion-Selective Electrodes for Potentiometric Determination of Paroxetine Hydrochloride in Pharmaceutical Preparations and Biological Fluids.
- Published in:
- Electroanalysis, 2014, v. 26, n. 12, p. 2789, doi. 10.1002/elan.201400366
- By:
- Publication type:
- Article
Plasma levels of interleukin‐8 and response to paroxetine in patients with major depressive disorder.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 6, p. 1, doi. 10.1002/hup.2855
- By:
- Publication type:
- Article
Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 5, p. 334, doi. 10.1002/hup.2479
- By:
- Publication type:
- Article
Persistent benefits of slow titration of paroxetine in a six-month follow-up.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 5, p. 329, doi. 10.1002/hup.2478
- By:
- Publication type:
- Article
Serotonin reuptake inhibitors and breastfeeding: a systematic review.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2015, v. 30, n. 1, p. 4, doi. 10.1002/hup.2451
- By:
- Publication type:
- Article
Addition of an NK<sub>1</sub> receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorder.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 6, p. 568, doi. 10.1002/hup.2444
- By:
- Publication type:
- Article
Benefit of slow titration of paroxetine to treat depression in the elderly.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 6, p. 544, doi. 10.1002/hup.2433
- By:
- Publication type:
- Article
Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 1, p. 7, doi. 10.1002/hup.2273
- By:
- Publication type:
- Article
Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 8, p. 602, doi. 10.1002/hup.1252
- By:
- Publication type:
- Article
Association between plasma paroxetine concentration and changes in plasma brain-derived neurotrophic factor levels in patients with major depressive disorder.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 3, p. 194, doi. 10.1002/hup.1192
- By:
- Publication type:
- Article
Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 1, p. 72, doi. 10.1002/hup.1165
- By:
- Publication type:
- Article
Differences in clinical effect and tolerance between fluvoxamine and paroxetine: A switching study in patients with depression.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 7/8, p. 525, doi. 10.1002/hup.1147
- By:
- Publication type:
- Article
No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2010, v. 25, n. 6, p. 487, doi. 10.1002/hup.1136
- By:
- Publication type:
- Article
Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2009, v. 24, n. 6, p. 489, doi. 10.1002/hup.1043
- By:
- Publication type:
- Article
The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: A double-blind crossover trial.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2008, v. 23, n. 5, p. 399, doi. 10.1002/hup.939
- By:
- Publication type:
- Article
Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 2, p. 375, doi. 10.1007/s00520-011-1118-8
- By:
- Publication type:
- Article
Paroxetine overdose during pregnancy.
- Published in:
- Forensic Sciences Research, 2021, v. 6, n. 3, p. 237, doi. 10.1080/20961790.2021.1938802
- By:
- Publication type:
- Article
帕罗西汀治疗阿尔兹海默症合并抑郁对血清 NE 以及 5-HT 表达的影响.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 21, p. 4080, doi. 10.13241/j.cnki.pmb.2020.21.017
- By:
- Publication type:
- Article
四七汤联合帕罗西汀治疗脑卒中后抑郁患者的疗效评价及对血清 ox-LDL、CRP、IL-6的影响
- Published in:
- Progress in Modern Biomedicine, 2018, v. 18, n. 21, p. 4148, doi. 10.13241/j.cnki.pmb.2018.21.033
- By:
- Publication type:
- Article
DSP-1053, a novel serotonin reuptake inhibitor with 5-HT<sup>1A</sup> partial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats.
- Published in:
- Pharmacology Research & Perspectives, 2015, v. 3, n. 3, p. 1, doi. 10.1002/prp2.142
- By:
- Publication type:
- Article
BDNF Gene Polymorphisms are Associated with Alzheimer's Disease-Related Depression and Antidepressant Response.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 26, n. 3, p. 523, doi. 10.3233/JAD-2011-110113
- By:
- Publication type:
- Article
Synapsin IIb as a functional marker of submissive behavior.
- Published in:
- Scientific Reports, 2015, p. 10287, doi. 10.1038/srep10287
- By:
- Publication type:
- Article
Non-Steroidal Drug Interferences in a Quantitative Multisteroid LC-MS/MS Assay.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 2, p. 329, doi. 10.3390/cells12020329
- By:
- Publication type:
- Article
National patterns of paroxetine use among US Medicare patients from 2015--2020.
- Published in:
- Frontiers in Psychiatry, 2024, p. 01, doi. 10.3389/fpsyt.2024.1399493
- By:
- Publication type:
- Article
Sertraline, citalopram and paroxetine in lactation: passage into breastmilk and infant exposure.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1414677
- By:
- Publication type:
- Article
Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1145070
- By:
- Publication type:
- Article
GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1032497
- By:
- Publication type:
- Article
Cross-sectional networks of depressive symptoms before and after antidepressant medication treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A case of galactorrhea during paroxetine treatment.
- Published in:
- International Journal of Psychiatry in Medicine, 2016, v. 51, n. 3, p. 302, doi. 10.1177/0091217416651257
- By:
- Publication type:
- Article
Ninety-six hours ordeal of priapism induced by paroxetine—A case report and literature review.
- Published in:
- International Journal of Psychiatry in Medicine, 2015, v. 50, n. 3, p. 326, doi. 10.1177/0091217415610312
- By:
- Publication type:
- Article
SSRIs vs. SNRIs for anxiety and OCD.
- Published in:
- Brown University Child & Adolescent Behavior Letter, 2020, v. 36, n. 3, p. 3, doi. 10.1002/cbl.30448
- By:
- Publication type:
- Article
Comparing the Effectiveness of Paroxetine, Attention Modification Program and Combination of both on Improving Social Anxiety Symptoms.
- Published in:
- Basic & Clinical Neuroscience, 2012, v. 3, n. 4, p. 36
- By:
- Publication type:
- Article
Paroxetine in the treatment of recurrent brief depressive disorder.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Comparative efficacies of fluoxetine and paroxetine in major depression across varying acute-phase treatment periods: A meta-analysis.
- Published in:
- Asia-Pacific Psychiatry, 2014, v. 6, n. 4, p. 353, doi. 10.1111/appy.12106
- By:
- Publication type:
- Article
A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms.
- Published in:
- International Journal of Women's Health, 2022, v. 15, p. 353, doi. 10.2147/IJWH.S282396
- By:
- Publication type:
- Article
The Antidepressants Amitriptyline and Paroxetine Induce Changes in the Structure and Functional Traits of Marine Nematodes.
- Published in:
- Sustainability (2071-1050), 2022, v. 14, n. 10, p. 6100, doi. 10.3390/su14106100
- By:
- Publication type:
- Article
Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2018, v. 52, n. 8, p. 751, doi. 10.1177/0004867418772351
- By:
- Publication type:
- Article
Paroxetine therapy for somatic delusion-Implications for underlying serotonergic dysfunction.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Lessons learned from Restoring Study 329: Transparent reporting, open databases and network metaanalyses as the way forward.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2017, v. 51, n. 4, p. 407, doi. 10.1177/0004867416676372
- By:
- Publication type:
- Article
Laughter therapy in a geriatric patient with treatment-resistant depression and comorbid tardive dyskinesia.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Restoring Study 329: Paroxetine neither effective nor safe for adolescents.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Paroxetine-induced dysarthria in a 42-year-old man with pathologic laughing.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2011, v. 45, n. 12, p. 1096, doi. 10.3109/00048674.2011.615290
- By:
- Publication type:
- Article
Correspondence.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2007, v. 41, n. 2, p. 192, doi. 10.1080/00048670601109980
- By:
- Publication type:
- Article
KAMBO FROG POISONING IN MEXICO.
- Published in:
- Archivos de Neurociencias, 2023, v. 28, n. 1, p. 34, doi. 10.31157/an.v28i1.415
- By:
- Publication type:
- Article
The Effect of Paroxetine on Ouabain-Induced Toxicity in Isolated Guinea Pig Atria.
- Published in:
- Acta Medica Iranica, 2011, v. 49, n. 4, p. 258
- By:
- Publication type:
- Article
MIXTURE AND SINGLE-SUBSTANCE ACUTE TOXICITY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN CERIODAPHNIA DUBIA.
- Published in:
- Environmental Toxicology & Chemistry, 2007, v. 26, n. 8, p. 1751, doi. 10.1897/06-265R.1
- By:
- Publication type:
- Article
A mixture model using likelihood-based and Bayesian approaches for identifying responders and non-responders in longitudinal clinical trials.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 5, p. 327, doi. 10.1002/pst.1637
- By:
- Publication type:
- Article